ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Medical University of South Carolina


Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingGemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; recurrent bladder cancer; stage III bladder cancer; stage IV bladder cancer
2.RecruitingGemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
3.RecruitingOpen-Label Phase 1 Dose Escalation Study of Intralesional Injection of M4N in Patients with Refractory Malignant Tumors of the Head and Neck
Condition: Head and Neck Neoplasms
4.RecruitingPEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
Condition: Stage IV Renal Cell Cancer
5.Not yet recruitingPhase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
Condition: Osteoporosis

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act